MUCCINI, CAMILLA
 Distribuzione geografica
Continente #
AS - Asia 988
NA - Nord America 954
EU - Europa 623
SA - Sud America 204
AF - Africa 46
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.827
Nazione #
US - Stati Uniti d'America 906
SG - Singapore 375
CN - Cina 334
IT - Italia 183
BR - Brasile 172
SE - Svezia 115
HK - Hong Kong 107
DE - Germania 106
VN - Vietnam 57
GB - Regno Unito 45
RU - Federazione Russa 42
FI - Finlandia 40
CA - Canada 28
JP - Giappone 20
ZA - Sudafrica 20
IN - India 18
AT - Austria 16
PL - Polonia 16
ES - Italia 15
MX - Messico 15
AR - Argentina 14
AU - Australia 10
FR - Francia 10
LT - Lituania 10
NL - Olanda 10
TR - Turchia 10
AE - Emirati Arabi Uniti 9
NG - Nigeria 9
PK - Pakistan 9
ID - Indonesia 8
BD - Bangladesh 7
BE - Belgio 6
EC - Ecuador 6
GH - Ghana 5
CH - Svizzera 4
CO - Colombia 4
IR - Iran 4
PH - Filippine 4
PS - Palestinian Territory 4
CY - Cipro 3
IQ - Iraq 3
MD - Moldavia 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
CL - Cile 2
ET - Etiopia 2
IL - Israele 2
JO - Giordania 2
MA - Marocco 2
MZ - Mozambico 2
SV - El Salvador 2
TZ - Tanzania 2
UY - Uruguay 2
UZ - Uzbekistan 2
BB - Barbados 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GT - Guatemala 1
IE - Irlanda 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
TV - Tuvalu 1
VE - Venezuela 1
Totale 2.827
Città #
Singapore 222
Dallas 180
Ashburn 124
Hong Kong 104
New York 89
Shanghai 88
Beijing 64
Munich 52
Hefei 49
Los Angeles 34
Boardman 33
Milan 33
Rome 32
Ho Chi Minh City 28
Helsinki 27
Nuremberg 23
São Paulo 23
Lawrence 22
Princeton 22
Moscow 21
Denver 20
Tokyo 20
Warsaw 16
Johannesburg 15
Houston 13
Orem 13
Poplar 13
Atlanta 12
Montreal 12
Council Bluffs 11
Hanoi 11
Washington 11
Guangzhou 10
London 10
Brooklyn 9
Seattle 9
Rio de Janeiro 8
Stockholm 8
Toronto 8
Boston 7
Chennai 7
Falkenstein 7
Phoenix 7
Vienna 7
Cesano Boscone 6
Chicago 6
Melbourne 6
Omaha 6
Sharjah 6
Turku 6
Accra 5
Ankara 5
Belo Horizonte 5
Brussels 5
Frankfurt am Main 5
Lagos 5
Lappeenranta 5
Manchester 5
Mexico City 5
San Francisco 5
Santa Clara 5
Shenzhen 5
Vittoria 5
Karachi 4
Lahore 4
Monsummano Terme 4
Pune 4
Quezon City 4
Romagnano Sesia 4
St Louis 4
Vauderens 4
Amsterdam 3
Angera 3
Buenos Aires 3
Cambridge 3
Chisinau 3
Columbus 3
Curitiba 3
Da Nang 3
Haiphong 3
Hangzhou 3
Honolulu 3
Ibadan 3
Jakarta 3
Las Vegas 3
Lima 3
Naples 3
New Delhi 3
Nicosia 3
Ottawa 3
Pouso Alegre 3
Querétaro 3
Rosalie Plains 3
Segrate 3
The Dalles 3
Vitória 3
Amman 2
Assago 2
Bibiana 2
Borås 2
Totale 1.750
Nome #
Evaluation of HIV reservoir in specific populations: people with a multi-drug resistant virus or a viral coinfection 257
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 131
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 106
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 94
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 93
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 78
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 75
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study 74
Achieving virological control in pan-resistant HIV-1 infection: A case series 71
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 70
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 69
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 67
Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen 67
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 65
Risk of Cardiovascular Diseases or Mortality in People with Higher Values of HIV-1 DNA 63
A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults 62
Association of high-risk sexual behaviours with sexually transmitted infections among men who have sex with men living with HIV 59
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV 57
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 57
Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV 57
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium 56
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting 56
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium 55
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 54
Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance 52
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients 52
Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy 52
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in Italy 52
Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection 51
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study 50
Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study) 50
Should we expect weight changes in people with HIV and a reported weight gain only by switching antiretroviral therapy? 49
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimen 49
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 47
Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents 47
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 46
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic 45
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 44
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting 43
Immune activation, inflammation and HIV DNA after 96 weeks of ATV/r monotherapy: A MODAt substudy 43
HIV Pol: does it offer therapeutic targets for HIV? 42
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 40
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV 36
Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimens 35
Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY 35
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV-specific risk factors; the Archi-Prevaleat project 31
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting 25
People with four-class drug-resistant HIV-1 may have low levels of intact DNA 25
All-Cause Mortality in People With Four-Class Drug-Resistant Human Immunodeficiency Virus: A Matched Cohort Analysis With Data From the PRESTIGIO Registry 9
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era 9
Totale 2.952
Categoria #
all - tutte 17.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.009


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 9 0 5 1 0 1 0
2021/202249 0 0 0 8 1 6 4 10 8 3 2 7
2022/2023202 52 44 11 3 8 18 25 22 5 2 6 6
2023/2024428 14 16 79 30 49 71 41 38 3 16 15 56
2024/2025877 66 28 19 33 79 90 120 109 90 49 59 135
2025/20261.375 245 187 220 388 313 22 0 0 0 0 0 0
Totale 2.952